Advertisement

Topics

Current FDA Policy Uncertainties Could Yield 'Reverse Impact' Of Support

16:33 EDT 4 May 2017 | SCRIP

At FDLI, both US FDA acting Commissioner Stephen Ostroff and BIO’s Kay Holcombe strike note of anticipating positive outcomes for...

      

Related Stories

 

Original Article: Current FDA Policy Uncertainties Could Yield 'Reverse Impact' Of Support

NEXT ARTICLE

More From BioPortfolio on "Current FDA Policy Uncertainties Could Yield 'Reverse Impact' Of Support"

Quick Search
Advertisement